Finally, a solution for your depression with Relief Psychedelics! We’re a REMS-certified provider of SPRAVATO®, an intranasal esketamine and the only FDA-approved psychedelic therapy on the market. SPRAVATO® is designed to help patients with treatment-resistant depression and major depression with suicidal thoughts or actions.
SPRAVATO® alters your mindset by accessing thoughts and ideas to help you achieve long-term wellness. It works differently than oral antidepressants by targeting the N-methyl-D-aspartate (NMDA) receptor. What’s more, SPRAVATO® is administered intranasally in an outpatient setting and doesn’t require an IV or needles.
